PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.41%
Revenue growth of 7.41% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
9.37%
Gross profit growth of 9.37% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
0.78%
EBIT growth of 0.78% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
22.36%
Operating income growth of 22.36% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
5.48%
Net income growth of 5.48% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
5.48%
EPS growth of 5.48% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
5.48%
Diluted EPS growth of 5.48% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
23.00%
10Y CAGR of 23.00% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
-5.88%
Negative 5Y CAGR while Healthcare median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-32.18%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
-100.00%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-100.00%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
No Data
No Data available this quarter, please select a different quarter.
38.40%
Net income/share CAGR of 38.40% while Healthcare median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
-5.96%
Negative 5Y CAGR while Healthcare median is 0.00%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-29.07%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
90.52%
Equity/share CAGR of 90.52% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
28.29%
5Y equity/share CAGR > 1.5x Healthcare median of 8.75%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
-15.26%
Negative 3Y equity/share growth while Healthcare median is 12.68%. Seth Klarman sees a short-term weakness if peers still expand net worth.
-41.67%
Dividend declines over 10 years while Healthcare median is 0.00%. Seth Klarman would see a relative disadvantage if peers consistently raised payouts.
-50.00%
Dividend cuts or stagnation while Healthcare median is 0.00%. Seth Klarman sees a disadvantage in shareholder returns vs. peers.
16.67%
3Y dividend/share CAGR of 16.67% while Healthcare is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
16779.31%
AR growth of 16779.31% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
3.78%
Inventory growth of 3.78% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
7.63%
Asset growth of 7.63% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
4.31%
BV/share growth of 4.31% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
12.23%
Debt growth of 12.23% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
-45.53%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.